PARSIPPANY, N.J., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 14, 2026 at 2:15 p.m. PT / 5:15 p.m. ET. Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company's investor relations website at investors.embecta.com. About embectaembecta is a global company that is advancing its 100-year legacy in insulin delive ...

Core Viewpoint - Medline Inc. has successfully completed its upsized initial public offering (IPO) of 248,439,654 shares of Class A common stock at a price of $29.00 per share, including the underwriters' option to purchase an additional 32,405,172 shares [1] Group 1: IPO Details - The proceeds from the issuance of 179,000,000 shares will be used to repay outstanding indebtedness under senior secured term loan facilities, with the remainder allocated for general corporate purposes and offering expenses [2] - Medline plans to use proceeds from the issuance of 37,034,482 shares and the additional shares purchased by underwriters to buy or redeem an equivalent number of outstanding equity interests from certain pre-IPO owners [2] - The Class A common stock of Medline is listed on the Nasdaq Global Select Market under the symbol "MDLN" [2] Group 2: Underwriters and Managers - Goldman Sachs & Co. LLC, Morgan Stanley, BofA Securities, and J.P. Morgan acted as global coordinators and lead bookrunning managers for the offering [2] - A wide range of firms, including Barclays, Citigroup, and Deutsche Bank Securities, served as bookrunning managers, while numerous others acted as co-managers for the offering [2] Group 3: Company Overview - Medline is the largest provider of medical-surgical products and supply chain solutions, serving all points of care [5] - The company has a broad product portfolio, resilient supply chain, and leading clinical solutions aimed at improving clinical, financial, and operational outcomes for healthcare providers [5] - Headquartered in Northfield, Illinois, Medline employs over 43,000 people globally and operates in more than 100 countries [5]

RT Giacomo Tognini (@giacomotognini)Medical supplies giant Medline went public today in this year's biggest IPO. @DurotMatthew and I dug into public filings for @Forbes and found that 5 members of the Mills family-who founded Medline in 1966 and sold a majority in 2021-are now billionaires.https://t.co/2JiRnVAdct ...

Economic Indicators - The November consumer price index (CPI) report is expected to show a 12-month inflation rate of 3.1%, with a core CPI (excluding food and energy) forecasted at an annual rate of 3.0% [2] - The Bureau of Labor Statistics noted that the release will not include 1-month percent changes for November 2025 due to the cancellation of the October inflation report [3] IPO Market - Medline, a medical supply giant, had a successful IPO, with shares jumping 41% on its debut, bringing its market capitalization to approximately $54 billion after opening at $35, up from its $29 IPO price [4] - Over 200 IPOs have been priced this year despite market volatility, marking the largest U.S. listing since Rivian's $13.7 billion deal in November 2021 [5] Corporate Leadership Changes - Glen Hauenstein, president of Delta Air Lines, will retire at the end of February after 20 years with the company, during which he helped position Delta as a leader in profitability [7] - Some of Delta's strategies, such as raising entry requirements for its SkyClubs, have faced customer pushback [8]

If 21st-century markets were an episode of The Andy Griffith Show, this news might have cued Gomer Pyle’s trademark line, “Surprise, surprise, surprise.” The biggest IPO of 2025 has no connection to artificial intelligence, semiconductors or data centers. It’s for a company that makes hospital gowns. On Wednesday, shares of medical supply company Medline jumped 40% in their Nasdaq debut, closing at $40 a pop after being priced at $29 in an IPO valued at $6.3 billion. SUBSCRIBE:  Receive more of our free ...

Core Insights - Medline has launched the largest IPO in over four years with a $6.26 billion offering, marking a significant event in the healthcare sector [1] Company Overview - Medline is the largest provider of medical surgical products and supply chain solutions for the healthcare industry, with revenue primarily derived from product sales [1][2] - The company operates a membership model similar to Costco, providing healthcare providers with competitive pricing through its supply chain business [3] Financial Performance - Medline has demonstrated solid revenue growth, with increases of 8.3% in 2023, 9.8% in 2024, and 10.3% through the first nine months of 2025, indicating accelerating growth trends [4]

Medline Inc. shares surged 41% in their trading debut, after the medical supplier raised $6.26 billion in the year’s biggest initial public offering. The shares closed at $41 each on Wednesday in New York, versus the IPO price of $29. Medline, which counts Blackstone Inc., Carlyle Group Inc. and Hellman & Friedman among its backers, sold 216 million shares in an upsized offering that priced near the top of the marketed range. Most Read from Bloomberg The trading gives the company a market value of abou ...

And right now we are 2 minutes away from the end of the trading day. Romaine Bostick alongside Katie Greifeld, taking you through to that closing bell with a global simulcast. We're joined now by Carol Massar and Tim Stenovec from the radio room.Welcome to our audiences across all of our Bloomberg platforms, including our partnership with YouTube. A decidedly down day. Stocks at session lows right now as we get just less than 2 minutes to those bells and Carol Massar, we're going to close below some key mov ...

Medline (MDLN) stock rose 40% on Wednesday to close at $40.66, as investors warmly greeted the year's biggest IPO on one of the last trading days of the year. The medical supply giant said late Tuesday that it had raised $6.26 billion in its IPO, selling a little over 216 million shares at $29 each, with the stock set to begin trading on Wednesday. Based on a total Class A share count of around 1.3 billion, the company's market cap stood north of $50 billion at the close of trading on Wednesday. Privat ...

Medline shares surged more than 40% in their hotly anticipated New York debut on Wednesday, valuing the medical supply giant at $54 billion in the largest US initial public offering since Rivian’s 2021 listing, capping a strong year for new listings and fueling optimism for 2026.Shares of the company opened at $35, compared with its IPO price of $29 per share. The stock closed at $41.The medical supplies maker and distributor — acquired for $34 billion in 2021 by Blackstone, Carlyle and Hellman & Friedman i ...